Forum Replies Created
-
AuthorPosts
-
Hello, this is Asif from Incepta.
We use 1:1 solid dispersion of Ledipasvir with Copovidone where Ledipasvir is in the amorphous form. This is exactly same as that of the innovator. We don’t make our API, we source it from China.
I wouldn’t say our drug provides 100% success rate, no drug does. But we know a number of patients achieving SVR 12 with Twinvir.
Asif Mostafa
M. Pharm (DU), MBA (IBA)
Senior Brand Manager
Incepta Pharmaceuticals Ltd.
40 Shahid Tajuddin Sharani,Tejgaon 1/A, Dhaka-1208
Phone:8891688-703 (Ex. 155)
Fax: +880-2-8891190
Mobile: +88-01713-338492
Available at Viber and whatsapp
E-mail: amostafa@inceptapharma.comHello Thurl,
Twinvir was launched on 27th of August. I launched the product. Patients started using this medicine from September earliest. SVR 12 is measured 12 weeks after treatment cessation. So no, there hasn’t been sufficient time to measure to SVR12 is any patients. But there are a number of patients who had been undetectable viral load during treatment. You are taking Twinvir. Have you measured your viral load during this time. What is your viral load status? I haven’t read the comment of the New Zealand doctor. Can you share the link with me?
Asif Mostafa
M. Pharm (DU), MBA (IBA)
Senior Brand Manager
Incepta Pharmaceuticals Ltd.
40 Shahid Tajuddin Sharani,Tejgaon 1/A, Dhaka-1208
Phone:8891688-703 (Ex. 155)
Fax: +880-2-8891190
Mobile: +88-01713-338492
Available at Viber and whatsapp
E-mail: amostafa@inceptapharma.com -
AuthorPosts
